Get the Stockscreener App
0.75
3.20%
-0.0248
22nd Century Group, Inc. stock is traded at $0.75, with a volume of 138.61K.
It is down -3.20% in the last 24 hours and down -7.29% over the past month.
22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. In addition, it engages in contract manufacturing business for third-party branded tobacco products. The company has scientific collaborations with the University of Virginia and Anandia Laboratories, Inc. to develop proprietary hemp strains with less than 0.3% dry weight content of delta-9-tetrahydrocannabinol. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.
See More
Previous Close:
$0.7748
Open:
$0.78
24h Volume:
138.61K
Relative Volume:
0.19
Market Cap:
$5.71M
Revenue:
$29.78M
Net Income/Loss:
$-39.94M
P/E Ratio:
-0.0121
EPS:
-61.9139
Net Cash Flow:
$-16.12M
1W Performance:
-14.58%
1M Performance:
-7.29%
6M Performance:
-94.41%
1Y Performance:
-99.49%
1-Day Range:
$0.75
$0.79
1-Week Range:
$0.74
$0.8731
52-Week Range:
$0.70
$147.15
22nd Century Group, Inc. Stock (XXII) Company Profile
Name
22nd Century Group, Inc.
Sector
Industry
Phone
716-270-1523
Address
8560 Main Street, Williamsville, NY
Compare XXII with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XXII
22nd Century Group, Inc.
|
0.75 | 5.59M | 29.78M | -39.94M | -16.12M | -61.91 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-21-22 | Initiated | Alliance Global Partners | Buy |
| Jun-15-22 | Initiated | Craig Hallum | Buy |
| Mar-08-22 | Initiated | ROTH Capital | Buy |
| Jul-23-21 | Initiated | Cowen | Outperform |
| Oct-16-17 | Reiterated | Chardan Capital Markets | Buy |
| Aug-11-16 | Reiterated | Chardan Capital Markets | Buy |
View All
22nd Century Group, Inc. Stock (XXII) Latest News
22nd Century Modifies Securities Purchase Agreement - TipRanks
Emerging Growth Research Releases Q1 2025 Update Report on 22nd Century Group - The Globe and Mail
22nd Century to Present at the Emerging Growth Conference on May 21, 2025 | XXII Stock News - GuruFocus
12 Cannabis Stocks to Buy Now in 2025 - MarketBeat
22nd Century to Present at the Emerging Growth Conference on May 21, 2025 - The Manila Times
22nd Century Group, Inc. CEO Larry Firestone to Present Corporate Update at Emerging Growth Conference on May 21, 2025 - Nasdaq
22nd Century Group Further Reduces Debt By $1.0 Million Following Financing Transaction - marketscreener.com
22nd Century Group, Inc. (NASDAQ:XXII) Q1 2025 Earnings Call Transcript - Insider Monkey
22nd Century Sees 50% Jump from Q4 2024 to Q1 2025 - Tobacco Reporter
22nd Century: Q1 Earnings Snapshot - CT Insider
22nd Century Group Inc (XXII) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic ... - Yahoo Finance
22nd Century Group Inc (XXII) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Restructuring - GuruFocus
22nd Century Group reports Q1 2025 earnings By Investing.com - Investing.com Nigeria
Earnings call transcript: 22nd Century Group Reports Q1 2025 Revenue Surge - Investing.com Australia
22nd Century Group Reports First Quarter 2025 Financial Results - GuruFocus
22ND CENTURY GROUP Earnings Results: $XXII Reports Quarterly Earnings - Nasdaq
22nd Century Group reports Q1 2025 earnings - Investing.com
22nd Century Group Reports 50% Sequential Sales Increase in First Quarter 2025, Advances Growth Strategy and New Product Launches - Nasdaq
22nd Century Group, Inc. (XXII): Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action and Deadline March 22, 2019 - ACCESS Newswire
Weiss Ratings Reiterates Sell (E) Rating for 22nd Century Group (NASDAQ:XXII) - Defense World
22nd Century files to sell 7.09M shares of common stock for holders - MSN
22nd Century Group Completes Sale of Needle Rock Farms Assets - The Manila Times
22nd Century Group Completes Sale of Needle Rock Farms Assets | XXII Stock News - GuruFocus
22nd Century Group, Inc. Enhances Balance Sheet with $770,000 Asset Sale Proceeds - Nasdaq
22nd Century Group reduces debt by $3.8 million - Investing.com Canada
22nd Century Group reduces debt by $3.8 million By Investing.com - Investing.com South Africa
Tag: Larry Firestone - Tobacco Reporter
22nd Century Further Reduces Debt by $1M - Tobacco Reporter
22nd Century Group (XXII) Reduces Debt by Another $1 Million | X - GuruFocus
22nd Century Group, Inc. Reports $1 Million Debt Repayment, Achieving $3.8 Million Year-to-Date Reduction - Nasdaq
22nd Century Group Further Reduces Debt by $1.0 Million Following Financing Transaction - The Manila Times
22nd Century Announces Q1 Webcast - Tobacco Reporter
22nd Century Group to Announce First Quarter 2025 Results on May 13, 2025 - The Manila Times
Press Release Distribution & PR Platform - ACCESS Newswire
22nd Century Group Stock Rises On Proposed FDA Mandate On Nicotine Content: Retail's Extremely Bullish - MSN
22nd Century Group, Inc. Stock (XXII) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.89%
3.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):